Analytical Data
-
基因名
Itgax
- Application
-
别名
CD11 antigen-like family member C Leukocyte adhesion glycoprotein p150,95 alpha chain Leukocyte adhesion receptor p150,95 CD_antigen: CD11c
-
种属
Mouse
-
表达系统
Baculovirus
-
标签
N- MBP & C- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9QXH4
-
表达区间
20-1116aa
-
分子量
165.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Itgax, also known as integrin alpha X, is a member of the integrin family of proteins, which play crucial roles in cell adhesion, migration, and signaling processes. Itgax is predominantly expressed in immune cells, particularly in monocytes, macrophages, and dendritic cells, where it is involved in immune responses and inflammatory processes. Research on Itgax has gained momentum due to its association with various diseases, including autoimmune disorders, cancer, and chronic inflammatory conditions. The reconstitution of Itgax in laboratory settings allows scientists to study its structural and functional properties, providing insights into its role in cell communication and tissue homeostasis. Understanding Itgax's mechanisms could lead to novel therapeutic strategies targeting immune modulation and improving treatment outcomes for related diseases. Additionally, the development of Itgax-based biomolecules holds promise for advancing targeted therapies and enhancing vaccine efficacy. As such, this protein remains a significant focus in immunological and biomedical research, highlighting the importance of elucidating its functional dynamics in health and disease.
